Body weight and oral contraceptives are the most important modulators of serum CRP levels

被引:21
作者
Buchbinder, S. [1 ]
Kratzsch, J. [1 ]
Fiedler, G. M. [1 ]
Yar, V. [2 ]
Bruegel, M. [1 ]
Leichtle, A. [1 ]
Weber, W. [3 ]
Alexander, H. [3 ]
Matthes, G. [2 ]
Thiery, J. [1 ]
机构
[1] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diag, Leipzig, Germany
[2] Univ Hosp Leipzig, Inst Transfus Med, Leipzig, Germany
[3] Univ Hosp Leipzig, Dept Gynaecol, Leipzig, Germany
关键词
age groups; body mass index; C-reactive protein; estrogens; lipids;
D O I
10.1080/00365510701487727
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
Background. C-reactive protein (CRP) levels are modulated by endogenous and exogenous factors independently of inflammation. The present study investigated the impact of oral contraceptives, endogenous oestrogens, age, gender, smoking, body mass index (BMI) and lipid levels on CRP concentrations in a healthy collective. Methods. Highly sensitive CRP, total cholesterol, HDL-cholesterol and LDL-cholesterol levels were measured in 850 blood donors (438 M, 412 F); 227 women in this group used oral contraceptive formulations (OC). Additionally, serum samples from 58 women undergoing in vitro fertilization cycles (IVF) were tested for CRP. Results. The 97.5th percentile of CRP levels of the blood donors was 4.91 mg/L in men, 7.52 mg/L in OC non-users and 11.95 mg/L in OC users. Overweight gives a 2-fold increase of median CRP levels in men and women. The combination of overweight and OC use in women resulted in 6-fold median CRP levels. Age, smoking and lipid levels were influencing factors of lower significance. In IVF patients the elevated oestradiol levels had no influence on CRP concentrations in multivariance analysis. Conclusion. The diagnostic and predictive value of CRP levels is most affected by BMI and oral contraceptive use, which suggests the need for further investigations into the role of CRP modulating factors in monitoring infectious diseases.
引用
收藏
页码:140 / 144
页数:5
相关论文
共 18 条
[1]
Risk factors for coronary heart disease and acute-phase proteins - A population-based study [J].
Danesh, J ;
Muir, J ;
Wong, YK ;
Ward, M ;
Gallimore, JR ;
Pepys, MB .
EUROPEAN HEART JOURNAL, 1999, 20 (13) :954-959
[2]
Oral contraceptive use and increased plasma concentration of C-reactive protein [J].
Dreon, DM ;
Slavin, JL ;
Phinney, SD .
LIFE SCIENCES, 2003, 73 (10) :1245-1252
[3]
Does exercise reduce inflammation? Physical activity and C-reactive protein among US adults [J].
Ford, ES .
EPIDEMIOLOGY, 2002, 13 (05) :561-568
[4]
Oral contraceptive use is associated with a systemic acute phase response [J].
Fröhlich, M ;
Döring, A ;
Imhof, A ;
Hutchinson, WL ;
Pepys, MB ;
Koenig, W .
FIBRINOLYSIS & PROTEOLYSIS, 1999, 13 (06) :239-244
[5]
Macrophage uptake of low-density lipoprotein bound to aggregated C-reactive protein: possible mechanism of foam-cell formation in atherosclerotic lesions [J].
Fu, T ;
Borensztajn, J .
BIOCHEMICAL JOURNAL, 2002, 366 (01) :195-201
[6]
High-sensitivity C-reactive protein in patients with metabolic syndrome [J].
Guven, Aytekin ;
Cetinkaya, Ali ;
Aral, Murat ;
Sokmen, Gulizar ;
Buyukbese, Mehmet Akif ;
Guven, Alanur ;
Koksal, Nurhan .
ANGIOLOGY, 2006, 57 (03) :295-302
[7]
Hafner G, 1995, CLIN LAB, V41, P743
[8]
Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: Effects of aspirin treatment [J].
Ikonomidis, I ;
Lekakis, J ;
Vamvakou, G ;
Andreotti, F ;
Nihoyannopoulos, P .
AMERICAN HEART JOURNAL, 2005, 149 (05) :832-839
[9]
Pro-inflammatory effects of oestrogens during use of oral contraceptives and hormone replacement treatment [J].
Kluft, C ;
Leuven, JAG ;
Helmerhorst, FM ;
Krans, HMJ .
VASCULAR PHARMACOLOGY, 2002, 39 (03) :149-154
[10]
LEICHTLE A, 2003, CLIN CHEM LAB MED, V41, pA72